INTRASENSE SAS (ALINS.PA) Stock Price, Forecast & Analysis

EPA:ALINS • FR0011179886

0.239 EUR
0 (-1.65%)
Last: Mar 2, 2026, 07:00 PM

ALINS.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap12.60M
Revenue(TTM)2.65M
Net Income(TTM)-6.48M
Shares52.72M
Float22.64M
52 Week High0.43
52 Week Low0.22
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.12
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2012-02-22
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
ALINS.PA short term performance overview.The bars show the price performance of ALINS.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

ALINS.PA long term performance overview.The bars show the price performance of ALINS.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 -10 -20 -30 -40

The current stock price of ALINS.PA is 0.239 EUR. In the past month the price decreased by -0.42%. In the past year, price decreased by -3.24%.

INTRASENSE SAS / ALINS Daily stock chart

ALINS.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
ALINS.PA Full Technical Analysis Report

ALINS.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to ALINS.PA. Both the profitability and financial health of ALINS.PA have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
ALINS.PA Full Fundamental Analysis Report

ALINS.PA Financial Highlights

Over the last trailing twelve months ALINS.PA reported a non-GAAP Earnings per Share(EPS) of -0.12. The EPS decreased by -56.42% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -70.48%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-39.79%
Sales Q2Q%33.25%
EPS 1Y (TTM)-56.42%
Revenue 1Y (TTM)13.56%
ALINS.PA financials

ALINS.PA Forecast & Estimates

7 analysts have analysed ALINS.PA and the average price target is 0.24 EUR. This implies a price increase of 2.43% is expected in the next year compared to the current price of 0.239.

For the next year, analysts expect an EPS growth of 37.5% and a revenue growth 71.49% for ALINS.PA


Analysts
Analysts40
Price Target0.24 (0.42%)
EPS Next Y37.5%
Revenue Next Year71.49%
ALINS.PA Analyst EstimatesALINS.PA Analyst Ratings

ALINS.PA Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
ALINS.PA Ownership

About ALINS.PA

Company Profile

ALINS logo image Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.

Company Info

INTRASENSE SAS

1231 Avenue du Mondial 98

Montpellier OCCITANIE FR

Employees: 76

ALINS Company Website

ALINS Investor Relations

Phone: 33467130130

INTRASENSE SAS / ALINS.PA FAQ

Can you describe the business of INTRASENSE SAS?

Intrasense SA engages in the design and development of advanced software solutions for viewing and analyzing of medical images. The company is headquartered in Montpellier, Occitanie. The company went IPO on 2012-02-22. The Company’s activities are divided into three divisions: sales of software for viewing and analyzing medical images; development of peripheral solutions;and supply of services. Its product portfolio comprises the Myrian line products are integrated into existing medical devices, such as Cr, Ultra sound and Nuclear imagining. Myrian Solutions are used for reconstruction of images from the Computed tomography(CT) scan, Magnetic Resonance Imaging (MRI) and Positron Emission Tomography scans, marketed under Myrian brand. The peripheral solutions provide materials for viewing digital images in the operating room, as well as various equipment, including printing servers and workstations, among others. The company offers also support, maintenance, as well as software rental and installation services for its products.


What is the current price of ALINS stock?

The current stock price of ALINS.PA is 0.239 EUR. The price decreased by -1.65% in the last trading session.


Does ALINS stock pay dividends?

ALINS.PA does not pay a dividend.


What is the ChartMill rating of INTRASENSE SAS stock?

ALINS.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Where is INTRASENSE SAS (ALINS.PA) stock traded?

ALINS.PA stock is listed on the Euronext Paris exchange.


What is the market capitalization of ALINS stock?

INTRASENSE SAS (ALINS.PA) has a market capitalization of 12.60M EUR. This makes ALINS.PA a Nano Cap stock.